Hypoglycaemia during Treatment of Type 2 Diabetes: Dangerous Complication..... But Avoidable with Modern Non-Insulin Therapy
Keywords:
Hypoglycaemia, Type 2 diabetes, Pioglitazone, GLP-1 mimetics, DPP4 inhibitors, SGLT2 inhibitorsAbstract
Hypoglycaemia is a dangerous complication that could occur while treating diabetes. Inpatients with type 2 diabetes, avoidance of hypoglycaemia is desirable in all; and absolutely necessary in many. Currently, clinicians have access to a variety of medications that achieve the dual objective of reaching targets and avoiding hypoglycaemia.
This brief review aims to highlight the dangers of hypoglycaemia and to familiarize clinicians with non-insulin based medications that avoid hypoglycaemia while treating patients with type 2 diabetes mellitus.
Downloads
Published
2016-09-29
Issue
Section
Review Article
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.